This one protein prevents muscle from turning to fats |
Human biology is not just surprising, but at the same time it is ever-evolving; a recent study has…
Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
CAMBRIDGE, Mass., November 14, 2025–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases,…
UTSW Molecular Biologist Wins Prestigious Columbia Prize for Work on Duchenne Muscular Dystrophy » Dallas Innovates
Eric Olson, Ph.D. [Photo: UTSW] Eric Olson, Ph.D., founding chair of molecular biology at UT Southwestern Medical Center…
Sarepta Says Deaths of Two Elevidys Patients Posted on FDA Database Unrelated to Treatment
Sarepta Therapeutics (NASDAQ: SRPT) said Friday that the deaths of two patients taking its marketed gene therapy Elevidys®…
Duchenne Muscular Dystrophy Market to Witness Significant
New York, USA, July 28, 2025 (GLOBE NEWSWIRE) — Duchenne Muscular Dystrophy Market to Witness Significant Expansion During…
New DMD Therapy Inhibits Glutamate Dehydrogenase 1
Credit: Sinhyu / iStock / Getty Images Plus Researchers at the VIB-KU Leuven Center for Brain and Disease…